FPRX
T. Rowe Price Associates’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-27,983
| Closed | -$1.05M | – | 2981 |
|
|
2021
Q1 | $1.05M | Sell |
27,983
-1,669,676
| -98% | -$62.9M | ﹤0.01% | 2018 |
|
|
2020
Q4 | $28.9M | Buy |
+1,697,659
| New | +$28.9M | ﹤0.01% | 1119 |
|
|
2020
Q2 | – | Sell |
-37,397
| Closed | -$85K | – | 2559 |
|
|
2020
Q1 | $85K | Buy |
37,397
+17,600
| +89% | +$40K | ﹤0.01% | 2427 |
|
|
2019
Q4 | $91K | Buy |
19,797
+1,658
| +9% | +$7.62K | ﹤0.01% | 2458 |
|
|
2019
Q3 | $70K | Buy |
18,139
+136
| +0.8% | +$525 | ﹤0.01% | 2466 |
|
|
2019
Q2 | $109K | Sell |
18,003
-1,004,444
| -98% | -$6.08M | ﹤0.01% | 2460 |
|
|
2019
Q1 | $13.7M | Sell |
1,022,447
-10,871
| -1% | -$146K | ﹤0.01% | 1266 |
|
|
2018
Q4 | $9.61M | Sell |
1,033,318
-7,936
| -0.8% | -$73.8K | ﹤0.01% | 1314 |
|
|
2018
Q3 | $14.5M | Buy |
1,041,254
+3,313
| +0.3% | +$46.1K | ﹤0.01% | 1309 |
|
|
2018
Q2 | $16.4M | Sell |
1,037,941
-96,124
| -8% | -$1.52M | ﹤0.01% | 1264 |
|
|
2018
Q1 | $19.5M | Buy |
1,134,065
+852,858
| +303% | +$14.7M | ﹤0.01% | 1190 |
|
|
2017
Q4 | $6.16M | Buy |
+281,207
| New | +$6.16M | ﹤0.01% | 1394 |
|
|
2016
Q3 | – | Sell |
-39,045
| Closed | -$1.62M | – | 2574 |
|
|
2016
Q2 | $1.62M | Buy |
+39,045
| New | +$1.62M | ﹤0.01% | 1576 |
|
|
2016
Q1 | – | Sell |
-318,580
| Closed | -$13.2M | – | 2535 |
|
|
2015
Q4 | $13.2M | Sell |
318,580
-291,040
| -48% | -$12.1M | ﹤0.01% | 1217 |
|
|
2015
Q3 | $9.38M | Sell |
609,620
-11,190
| -2% | -$172K | ﹤0.01% | 1319 |
|
|
2015
Q2 | $15.4M | Sell |
620,810
-1,800
| -0.3% | -$44.7K | ﹤0.01% | 1221 |
|
|
2015
Q1 | $14.2M | Buy |
622,610
+205,000
| +49% | +$4.68M | ﹤0.01% | 1231 |
|
|
2014
Q4 | $11.3M | Buy |
417,610
+166,795
| +67% | +$4.5M | ﹤0.01% | 1292 |
|
|
2014
Q3 | $2.94M | Buy |
+250,815
| New | +$2.94M | ﹤0.01% | 1527 |
|